Details of issuance or disposal
Exercise of the Series 8 Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) and disposal of treasury shares
New shares: 0 shares; transferred treasury shares: 140,000 shares
¥3,304,000 paid in for the issuance of these Stock Acquisition Rights, ¥302,540,000 paid in upon exercise of these Stock Acquisition Rights, for a total of ¥305,844,000 (before deducting issuance-related expenses)
0% (There is no change in the total number of issued shares because treasury shares are being delivered.)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of the Series 8 Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) and disposal of treasury shares |
| Number of shares to be issued or disposed of | New shares: 0 shares; transferred treasury shares: 140,000 shares |
| Amount of funds to be raised | ¥3,304,000 paid in for the issuance of these Stock Acquisition Rights, ¥302,540,000 paid in upon exercise of these Stock Acquisition Rights, for a total of ¥305,844,000 (before deducting issuance-related expenses) |
| Specific use of funds | Details Expenses related to M&A and capital and business alliances / Amount Not disclosed / Scheduled timing of expenditures Not disclosed |
| Intended allottee | グロース・キャピタル株式会社 (exerciser) |
| Dilution Rate | 0% (There is no change in the total number of issued shares because treasury shares are being delivered.) |
| Total number of issued shares | 10,390,644 shares (as of 30 September 2026) → 10,390,644 shares（0%） |
| Exercise price | ¥2,161 (no revision or adjustment from the initial exercise price; details of the exercise price adjustment provisions and the floor are Not disclosed) |
| Number of Stock Acquisition Rights | Total issued: 1,400 units; unexercised balance: 0 units (1,400 units at the end of the previous month) |
| Most recent equity financing | Timing 10 March 2025 / Type Issuance of the Series 8 Stock Acquisition Rights through a third-party allotment (with exercise price adjustment provisions) / Amount ¥3,304,000 paid in upon issuance, ¥302,540,000 paid in upon exercise, for a total of ¥305,844,000 |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This follows the bulk exercise of the Series 8 Stock Acquisition Rights issued on 10 March 2025 during the period from 1 October to 15 October 2026, with all exercises now completed. The funds raised are scheduled to be used for costs related to M&A and capital and business alliances.